US/UK/Canada

Share

Pick a time period -
Tags ( Active)

UTA’s AbeXXa Biologics named one of 40 "Best University Startups 2017" by National Council of Entrepreneurial Tech Transfer

AbeXXa is identifying a new series of biomarkers or targets for cancer from the many thousands of proteins found within a tumor cell, a new field of research that could potentially result in immunotherapies that prove effective for a broad range of patientsAbeXXa Biologics, a faculty startup at The University of Texas at Arlington, was named one of the 40 “Best University Startups 2017” by the National Council of Entrepreneurial Tech Transfer, a Washington-based association of startup officers from the top research universities in the United States. AbeXXa Biologics co-founder and chief

UTA biologist concludes that the body’s own immune system regulates bacterial communities in the intestine to promote health

Researchers at the University of Texas at Arlington and University of Utah have concluded that the body’s own immune response regulates the composition of bacterial communities in the intestine that improve health and help fight off infections. Differences in the quality of this immune response and the composition of the bacteria in the intestine determine an individual’s susceptibility to inflammatory diseases like Crohn’s disease or ulcerative colitis, as well as infectious diseases like Salmonellosis or Listeriosis. Because of genetic differences between people, this immune response

UTA names immunology expert and entrepreneur Jon Weidanz associate vice president for research

Weidanz will also take on a role as professor of biologyThe University of Texas at Arlington has appointed Dr. Jon Weidanz, founding chairman of the department of immunotherapeutics and biotechnology in the School of Pharmacy at Texas Tech University Health Sciences Center, as associate vice president for research and professor of biology. Dr. Weidanz has more than 20 years of experience in biotechnology research with emphasis in immunology, immunotherapy and immunodiagnostic product development, especially related to oncology and the development of products to diagnose and treat cancer.

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media